Long Ideas - Shares of Questcor Pharmaceuticals (QCOR) have started to rise to more realistic valuations in the new year (as PropThink expected), breaking $31 dollars on Tuesday … Continue Reading
Read nowLong Ideas - Shares of Chelsea Therapeutics (CHTP) opened sharply higher on news Wednesday that FDA has provided the company with a new pathway for approval of Northera. … Continue Reading
Read nowLong Ideas - To those following the story (and PropThink’s coverage), it should come as little surprise that Cornerstone Therapeutics’ (CRTX) majority shareholder Chiesi Farmaceutici SpA is making … Continue Reading
Read nowLong Ideas - Short interest in Raptor Pharmaceuticals (RPTP) increased by 6% over the last two months, in tandem with the stock’s rise to $6.28, which has since … Continue Reading
Read nowMost Popular - Shares of ResMed Inc. (RMD) have finally found their top, peaking at $48.37 in late January before dropping to the $43 level. But the downslide … Continue Reading
Read nowLong Ideas - A letter from Fresenius Medical (FMS) on Tuesday stated that the nation-wide dialysis provider would pause expansion of its pilot program utilizing Omontys, Affymax’s (AFFY) … Continue Reading
Read nowLong Ideas - Achillion Pharmaceuticals (ACHN) reported positive clinical trial results for ACH-3102, the company’s NS5A inhibitor for hepatitis C (HCV). Achillion remains a leading independent mid-stage biotech … Continue Reading
Read now